Urgent new Napralief warning as naproxen brand recalled over patient safety fears

Urgent new Napralief warning as naproxen brand recalled over patient safety fearsThe pain-relief medication is used to treat people with a range of conditions including sore muscles and joints, sporting injuries and period painNewsElaine Blackburne Network Content Editor12:02, 23 Apr 2026Updated 12:03, 23 Apr 2026View 3 ImagesSome specific batches have been recalled(Image: Getty)Patients using a common pain-relief medication have been issued advice after safety concerns were raised.‌Omega Pharma Limited is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets as a precautionary measure due to important safety and dosage information being missing from the patient information leaflet (PIL) and outer carton. Napralief 250mg contains the active ingredient naproxen and is a non-steroidal anti-inflammatory drug (NSAID) used to treat muscle or joint pain, such as sprains and strains, inflammation caused by sporting injuries, lower back pain, neck pain or pain in the wrists or feet. It is also used to treat period pain.‌Three batches are affected by this recall. These can be identified by checking the packaging for batch numbers B51496, B51497, and B51102.‌View 3 ImagesThe drug is used to treat pain in a number of areas(Image: Getty)The affected cartons do not include the instruction that patients must not take more than three tablets a day, which is a key dosage safety message intended to prevent overuse. In addition, the PIL is missing dosage instructions which state that on the first day patients should take two tablets, followed by one tablet 6-8 hours later. For the second and third day of treatment, if needed, one tablet (250mg) should be taken every 6–8 hours.The PIL is also missing advice that patients should have an eye examination if they develop visual disturbances, warnings that serious allergic reactions can occur even in people with no previous allergy to painkillers, and guidance to inform a doctor if blood or urine tests are needed, as treat...